As of Mar 05
| +0.0017 / +0.34%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 5.57, with a high estimate of 5.57 and a low estimate of 5.57. The median estimate represents a +1,002.61% increase from the last price of 0.51.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.